TeleMed2U
TeleMed2U is a general telehealth platform founded in approximately 2013 in Sacramento, California — making it one of the longer-operating telemedicine companies in the US market. Unlike the wave of GLP-1-specific platforms that emerged during the semaglutide shortage period, TeleMed2U is a primary care and specialty telehealth service that offers GLP-1 prescriptions as part of broader weight management care, not as a standalone product.
Overview
- Consultation Model
- Hybrid
- Headquarters
- Sacramento, CA
- Shipping
- 3-5 business days
- Lab Testing
- No
- Prescriber Info
- Licensed healthcare providers evaluate patients and prescribe based on clinical eligibility.
- Founded
- 2013
Pros
- Insurance accepted for consultations
- Established since 2013
- Primary care breadth means GLP-1 treatment is embedded in comprehensive care, not isolated from the rest of your health
- Video consultations with physicians
- Branded GLP-1 prescriptions through primary care are a more straightforward regulatory pathway than compounding
- California regulation and longer track record provide some additional baseline accountability
Cons
- Not a GLP-1-specialist platform
- Branded GLP-1 medications can be expensive without strong insurance coverage; patients without obesity coverage may face high out-of-pocket medication costs
- Requires scheduled video appointments
- Insurance acceptance means billing complexity; not all plans cover telehealth visits or GLP-1 medications equally
- Less marketing visibility than dedicated GLP-1 platforms, which can make it harder to find patient reviews and comparative information